Bosutinib - CAS# 380843-75-4 287 0 µM concentration

0 µM concentration

Neurogastroenterol Motil

Synthesized compounds from ceanothic acid have been shown to inhibit Epstein-Barr virus early antigen activation in anti-cancer research

It is a component of tegafur-uracil

Bosutinib - CAS# 380843-75-4 287 0 µM concentrationBosutinib, also known as SKI 606, is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid